What is the present valuation and projected CAGR of the oral solid dosage pharmaceutical formulation market?
The oral solid dosage pharmaceutical formulation market size has grown strongly in recent years. It will grow from $618.34 billion in 2024 to $659.54 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to chronic disease prevalence, aging population, healthcare access expansion, generic formulation promotion, and consumer preference shift.
The oral solid dosage pharmaceutical formulation market size is expected to see strong growth in the next few years. It will grow to $842.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to personalized medicine demand, controlled-release adoption, biopharmaceutical focus, emerging market expansion, and policy and reimbursement changes. Major trends in the forecast period include personalized medicine adoption, digital health integration, the rise of telemedicine services, focus on preventive healthcare, and continued expansion of artificial intelligence in healthcare.
Get Your Free Sample of The Global Oral Solid Dosage Pharmaceutical Formulation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15626&type=smp
Which Market drivers have played a significant role in driving the oral solid dosage pharmaceutical formulation market?
The increasing prevalence of chronic diseases is expected to propel the growth of the oral solid dosage pharmaceutical formulation market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. Chronic diseases are rising due to factors such as aging populations, sedentary lifestyles, poor dietary habits, environmental factors, and improved detection and diagnosis methods. Oral solid dosage pharmaceutical formulations are integral to chronic disease management and support long-term treatment adherence, as they are convenient, stable, and precise dosing. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 35 million new cancer cases were projected by 2050, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases drives the growth of the oral solid dosage pharmaceutical formulation market.
What are the key segments within the oral solid dosage pharmaceutical formulation market?
The oral solid dosage pharmaceutical formulation market covered in this report is segmented –
1) By Dosage Form: Tablets, Capsules, Powders And Granules, Lozenges And Pastilles, Gummies
2) By Mechanism: Controlled-Release, Immediate-Release, Delayed-Release
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Hypermarkets Or Supermarkets
4) By End-User: Large-Size Companies, Medium And Small-Size Companies, Other End-Users
Subsegments:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Controlled-Release Tablets, Effervescent Tablets, Chewable Tablets, Sublingual Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Liquid-Filled Capsules, Delayed-Release Capsules
3) By Powders And Granules: Oral Powders (Reconstitution), Granules (Oral Suspension Or Dispersible Granules)
4) By Lozenges And Pastilles: Medicinal Lozenges, Herbal Lozenges, Sugar-Free Lozenges, Pastilles ( Throat Or Cough Relief)
5) By Gummies: Vitamin Gummies, Herbal And Nutritional Supplement Gummies, Pharmaceutical Gummies ( Pain Relief Or Sleep Aids)
Order your report now for swift delivery
Which key players are shaping the oral solid dosage pharmaceutical formulation market?
Major companies operating in the oral solid dosage pharmaceutical formulation market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc., Novartis AG, Hoffman-La-Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim GmbH, Gilead Sciences, Amgen Inc., Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Biogen Inc., Lonza Group, Catalent Inc., Ashland Inc., Piramal Pharma Solutions, Jubilant Pharmova, CordenPharma International
Which transformative trends will shape the oral solid dosage pharmaceutical formulation market landscape?
Major companies operating in the oral solid dosage pharmaceutical formulation market are developing innovative products, such as liquid-filled capsules, to enhance drug delivery, improve bioavailability, and offer more convenient dosing options for patients. Liquid-filled capsules are oral dosage forms consisting of a gelatin shell filled with a liquid or semi-solid formulation containing active pharmaceutical ingredients (APIs) and excipients. For instance, in July 2023, Zeon Lifesciences Ltd., an India-based pharmaceutical company, launched liquid-filled capsules, offering a cutting-edge delivery system with enhanced bioavailability and absorption rates. These capsules feature an innovative delivery system that enhances bioavailability and absorption rates, ensuring optimal levels of active ingredients for maximum efficacy and immediate results. Zeon’s liquid-filled capsules provide precise and consistent dosages, improving patient compliance and control over medication administration. These capsules utilize advanced technologies to enhance bioavailability, improve patient outcomes, and protect the medication’s integrity. Zeon’s liquid-filled capsules offer a convenient, effective, and reliable alternative to traditional dosage forms, setting a new standard for patient care and compliance in the pharmaceutical industry.
How do regional factors impact the oral solid dosage pharmaceutical formulation market, and which region is the largest contributor?
North America was the largest region in the oral solid dosage pharmaceutical formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral solid dosage pharmaceutical formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Oral Solid Dosage Pharmaceutical Formulation Market Report 2025 Offer?
The oral solid dosage pharmaceutical formulation market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Oral solid dosage pharmaceutical formulation refers to a type of medication administered orally in a solid form. These formulations are designed to be swallowed and then dissolved or dispersed in the gastrointestinal tract, where the active pharmaceutical ingredients (APIs) are absorbed into the bloodstream to exert their therapeutic effects. Oral solid dosage pharmaceutical formulations are a cornerstone of modern medicine, offering a reliable, convenient, and effective method for drug delivery.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15626
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
